Database » Support Infrastructure » Tech Parks & Incubators » Bioline Innovations Jerusalem

Bioline Innovations Jerusalem

First Israeli biotech incubator supported by the Israeli OCS national biotechnology initiative. As the sole recipient of a $21 million grant for the development of pre-clinical compounds, BIJ is uniquely positioned to take early stage compounds through rigorous pre-clinical tests on their way to clinical trials. BIJ preclinical tasks provide an additional level of comfort on safety and efficacy, and serve as the basis for Investigative New Drug (IND) applications. These tasks include chemistry and formulation, dosage form, metabolism, pharmacokinetics and toxicology and use well accepted animal models for repetition of efficacy studies using GLP materials. Currently, there are over 10 drug development projects in pre-clinical development. BIJ is owned and operated by Bioline Rx whose major investors include renowned VCs as well as Teva Pharmaceuticals, Hadasit and the JDA.

Contact Info

Website http://www.biolinerx.com/BIJ_index.asp
Contact Person Dr. Kineret Savitski, General Manager
Email info@BioLineRx.com
Address 19 Hartum Street, P.O. Box 45158, Jerusalem 91450, Israel
Phone 972-2-548-9100
Fax 972-2-548-9101